Breakout Session II

Breakout Session Options:

  • How to Reduce Patient Burden in the Age of Complexity
  • Budgets in the Face of Evolving Economic Conditions
  • Coverage Analysis Explained: How to Avoid Non-Compliance


How to Reduce Patient Burden in the Age of Complexity
In this day and age, patient burden has a direct correlation with trial participation and enrollment. With sites struggling to maintain enrollment, what can sponsors and CROs do to assist sites in retaining patients? Join this session to hear from sites and industry partners discussing the complexity of protocols and how the industry can reduce the burden on patients, making this better for sites and trials in the long run.

Cheryl Seabrook-Brown, 
Regional Senior Clinical Research Associate, Merck

Michelle Cencelewski,
Vice President, Clinical Operations, Objective Health 
Dave Espenshade, VP, CRO Partnerships, Greenphire
Selin Kumaz, PhD,
Co-Founder and CEO, Massive Bio
Patricia Salter, Senior Director, Head of Global Decentralized Clinical Trial Operations, IQVIA


Budgets in the Face of Evolving Economic Conditions
A “good” budget can make or break a trial’s success, especially with rising operational costs. Have you wondered what other sites are doing that you may be missing? Learn from successful non-oncology sites what you can do to improve your budget to adjust for costs like inflation and tips for stronger negotiations. Join us for a full panel from a variety of sites as they discuss what savvy organizations do when facing challenging and evolving economic conditions.

Sandy Smith, RN, MSN, AOCN, SVP, Clinical Solutions & Strategic Partnering, WCG

Daniel Fox, MPH, PhD,
Founder/CEO, Clinical Research Payment Network; Land of Lincoln Clinical Research
Bouchra Sefiane-Rucker,
Sr. Local Associate Director, Global Medicines Development, Early Oncology, AstraZeneca
David Vulcano, LCSW, MBA, CIP, RAC, Vice President, Clinical Research Compliance & Integrity, HCA Healthcare


Coverage Analysis Explained: How to Avoid Non-Compliance
Billing compliance in clinical research is critical to a successful trial. The consequences of not following compliance standards are severe, potentially costing millions of dollars, as well as affecting reputations. The coverage analysis is a vital component of the study activation process and can save sites time, money, and their reputation in the future. With complex payments increasing, outsourcing Medicare Coverage Analysis is becoming more common. A comprehensive panel discussion will reflect on how this affects study startup. Join us as we break down consequences to non-compliance, as well as offer solutions to non-compliance in the future.

Dan Otap, CCRP, Principal, Alliance and Partnerships Lead, Genentech

Kathleen Hurtado, Associate Vice President, Cancer Treatment Centers of America
Jake Meyer,
Senior Manager, BOS, Advarra
Geoff Schick, MBA, CHRC, Director, Strategic Site Partnerships, WCG



Location: See App for Room Location Date: April 1, 2023 Time: 12:00 pm - 1:00 pm